InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

8.59
Delayed Data
As of Apr 20
 +0.34 / +4.12%
Today’s Change
7.71
Today|||52-Week Range
106.25
-55.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization135.0K129.0K123.0K8.0K
 
 
 
 
 
 
Operating ExpensesGross Income-135.0K-129.0K-123.0K-8.0K
 
 
 
 
 
General Expenses6.5M6.8M6.2M4.5M
 
 
 
 
 
Research And Development3.4M3.2M2.9M1.5M
 
 
 
 
 
Total Operating Expenses6.7M6.9M6.3M4.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.7M-6.9M-6.3M-4.5M
 
 
 
 
 
Extraordinary Credit241.0K554.0K0.000.00
 
 
 
Extraordinary Charge0.000.00-3.1M-163.0K
 
 
 
Interest Expense On Debt20.0K20.0K18.0K16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.4M-6.3M-9.4M-4.7M
 
 
 
 
 
Net Income-6.4M-6.3M-9.4M-4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.3M1.3M1.3M1.4M
 
 
 
 
 
Shares To Calculate EPS Diluted1.3M1.3M1.3M1.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.00-$5.00-$7.00-$3.25
 
 
 
 
 
EPS Diluted-$5.00-$5.00-$7.00-$3.40